Robotic Rehabilitation and Assistive Technologies Market Share

  • Report ID: 4581
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Robotic Rehabilitation and Assistive Technologies Market Share

North American Market Forecast   

The North America robotic rehabilitation and assistive technologies market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the rising chronic disease prevalence coupled escalating geriatric population, and a strong healthcare industry is expected to drive the growth of the market in North America during the forecast period. For instance, the U.S. has more than 54 million adults aged 65 and older, or roughly 16.5% of the population in 2022, according to the U.S.  Census Bureau. Apart from that higher prevalence of cardiovascular diseases (CVDs) in the region, backed by the growth in robotic rehabilitation and assistive technologies owing to the ongoing development of robotics in North America, is projected to enlarge the market’s size during the forecast period. As of 2019, nearly 40% of the population in the USA was diagnosed with cardiovascular diseases and approximately 6 million people lost their lives owing to stroke in a similar year. Therefore, all these factors are expected to drive the growth of the market in the region during the forecast period.

Research Nester
Robotic Rehabilitation and Assistive Technologies Market Growth
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4581
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of robotic rehabilitation and assistive technologies is evaluated at USD 2.59 Billion.

The robotic rehabilitation and assistive technologies market size was over USD 2.28 Billion in 2023 and is projected to exceed USD 12.24 Billion by the end of 2036, growing at over 13.8% CAGR during the forecast period i.e., between 2024-2036. Increasing incidence of orthopedic illnesses is the major factor driving the market growth.

North America is predicted to account for majority industry share by 2036, attributed to rising chronic disease prevalence coupled escalating geriatric population, and a strong healthcare industry.

AlterG, Inc., Bionik Laboratories Corp., Ekso Bionics Holdings, Inc., Vincent Medical Holdings Limited, Hocoma AG, CYBERDYNE Inc., Kinova inc., Rex Bionics Ltd, Instead Technologies Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample